{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:41Z","timestamp":1790665661881,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41375-023-02035-3","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:03:04Z","timestamp":1695736984000},"page":"2221-2230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"37","author":[{"given":"Ludovic","family":"Jondreville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Dehgane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-1306","authenticated-orcid":false,"given":"Cecile","family":"Doualle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luce","family":"Smagghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Davi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-5231","authenticated-orcid":false,"given":"Leticia K.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5744-5612","authenticated-orcid":false,"given":"Delphine","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Bravetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9438-621X","authenticated-orcid":false,"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouane","family":"Boubaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-7596","authenticated-orcid":false,"given":"Elise","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-1628","authenticated-orcid":false,"given":"Santos A.","family":"Susin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-6668","authenticated-orcid":false,"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"2035_CR1","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-11-2342","volume":"18","author":"JR Brown","year":"2012","unstructured":"Brown JR, Hanna M, Tesar B, Werner L, Pochet N, Asara JM, et al. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res: Off J Am Assoc Cancer Res. 2012;18:3791\u2013802.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"2035_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2141.2008.07373.x","volume":"143","author":"F Forconi","year":"2008","unstructured":"Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita PM, et al. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion. Br J Haematol. 2008;143:532\u20136.","journal-title":"Br J Haematol"},{"key":"2035_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0002-9440(10)64256-3","volume":"161","author":"S Bea","year":"2002","unstructured":"Bea S, Lopez-Guillermo A, Ribas M, Puig X, Pinyol M, Carrio A, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter\u2019s syndrome). Am J Pathol. 2002;161:957\u201368.","journal-title":"Am J Pathol"},{"key":"2035_CR4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/10428194.2013.845882","volume":"55","author":"J Houldsworth","year":"2014","unstructured":"Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, et al. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2014;55:920\u20138.","journal-title":"Leuk Lymphoma"},{"key":"2035_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2019.239947","volume":"106","author":"AC Leeksma","year":"2021","unstructured":"Leeksma AC, Baliakas P, Moysiadis T, Puiggros A, Plevova K, Van der Kevie-Kersemaekers AM, et al. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study. Haematologica. 2021;106:87\u201397.","journal-title":"Haematologica."},{"key":"2035_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152:714\u201326.","journal-title":"Cell."},{"key":"2035_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525\u201330.","journal-title":"Nature."},{"key":"2035_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1365-2141.2011.08789.x","volume":"154","author":"A Rinaldi","year":"2011","unstructured":"Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, et al. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. Br J haematol. 2011;154:590\u20139.","journal-title":"Br J haematol"},{"key":"2035_CR9","doi-asserted-by":"publisher","first-page":"80916","DOI":"10.18632\/oncotarget.13106","volume":"7","author":"G Blanco","year":"2016","unstructured":"Blanco G, Puiggros A, Baliakas P, Athanasiadou A, Garcia-Malo M, Collado R, et al. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations. Oncotarget. 2016;7:80916\u201324.","journal-title":"Oncotarget."},{"key":"2035_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11589","volume":"7","author":"JA Burger","year":"2016","unstructured":"Burger JA, Landau DA, Taylor-Weiner A, Bozic I, Zhang H, Sarosiek K, et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat Commun. 2016;7:11589.","journal-title":"Nat Commun"},{"key":"2035_CR11","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2005-05-2013","volume":"106","author":"F Rubio-Moscardo","year":"2005","unstructured":"Rubio-Moscardo F, Blesa D, Mestre C, Siebert R, Balasas T, Benito A, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood. 2005;106:3214\u201322.","journal-title":"Blood."},{"key":"2035_CR12","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131:2745\u201360.","journal-title":"Blood."},{"key":"2035_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","volume":"133","author":"P Baliakas","year":"2019","unstructured":"Baliakas P, Jeromin S, Iskas M, Puiggros A, Plevova K, Nguyen-Khac F, et al. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood. 2019;133:1205\u201316.","journal-title":"Blood."},{"key":"2035_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/gcc.22176","volume":"53","author":"A Cosson","year":"2014","unstructured":"Cosson A, Chapiro E, Belhouachi N, Cung H-A, Keren B, Damm F, et al. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma. Genes Chromosom Cancer. 2014;53:657\u201366.","journal-title":"Genes Chromosom Cancer"},{"key":"2035_CR15","doi-asserted-by":"publisher","first-page":"e76607","DOI":"10.1371\/journal.pone.0076607","volume":"8","author":"E Hertlein","year":"2013","unstructured":"Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, et al. Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. PloS ONE. 2013;8:e76607.","journal-title":"PloS ONE"},{"key":"2035_CR16","first-page":"e149","volume":"44","author":"J Cao","year":"2016","unstructured":"Cao J, Wu L, Zhang SM, Lu M, Cheung WK, Cai W, et al. An easy and efficient inducible CRISPR\/Cas9 platform with improved specificity for multiple gene targeting. Nucleic Acids Res. 2016;44:e149.","journal-title":"Nucleic Acids Res"},{"key":"2035_CR17","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3324\/haematol.2018.203430","volume":"104","author":"M Boudny","year":"2019","unstructured":"Boudny M, Zemanova J, Khirsariya P, Borsky M, Verner J, Cerna J, et al. Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells. Haematologica. 2019;104:2443\u201355.","journal-title":"Haematologica."},{"key":"2035_CR18","doi-asserted-by":"publisher","first-page":"8356","DOI":"10.1038\/sj.onc.1207004","volume":"22","author":"JB Johnston","year":"2003","unstructured":"Johnston JB, Kabore AF, Strutinsky J, Hu X, Paul JT, Kropp DM, et al. Role of the TRAIL\/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. Oncogene. 2003;22:8356\u201369.","journal-title":"Oncogene"},{"key":"2035_CR19","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2003-09-3236","volume":"104","author":"A Rosenwald","year":"2004","unstructured":"Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, et al. Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood. 2004;104:1428\u201334.","journal-title":"Blood"},{"key":"2035_CR20","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.1073\/pnas.1206062109","volume":"109","author":"W Xue","year":"2012","unstructured":"Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci USA. 2012;109:8212\u20137.","journal-title":"Proc Natl Acad Sci USA."},{"key":"2035_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ajh.24990","volume":"93","author":"E Chapiro","year":"2018","unstructured":"Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, et al. \u201cDouble-hit\\\u201c chronic lymphocytic leukemia: an aggressive subgroup with 17p deletion and 8q24 gain. Am J Hematol. 2018;93:375\u201382.","journal-title":"Am J Hematol"},{"key":"2035_CR22","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1182\/bloodadvances.2022008821","volume":"7","author":"S Bonfiglio","year":"2023","unstructured":"Bonfiglio S, Sutton LA, Ljungstrom V, Capasso A, Pandzic T, Westrom S, et al. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. Blood Adv. 2023;7:2794\u2013806.","journal-title":"Blood Adv"},{"key":"2035_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jcp.20392","volume":"205","author":"P Secchiero","year":"2005","unstructured":"Secchiero P, Tiribelli M, Barbarotto E, Celeghini C, Michelutti A, Masolini P, et al. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. J Cell Physiol. 2005;205:246\u201352.","journal-title":"J Cell Physiol"},{"key":"2035_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0378-4274(02)00422-8","volume":"139","author":"M MacFarlane","year":"2003","unstructured":"MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett. 2003;139:89\u201397.","journal-title":"Toxicol Lett."},{"key":"2035_CR25","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1074\/jbc.M410660200","volume":"280","author":"RF Kelley","year":"2005","unstructured":"Kelley RF, Totpal K, Lindstrom SH, Mathieu M, Billeci K, Deforge L, et al. Receptor-selective mutants of apoptosis-inducing ligand 2\/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J Biol Chem. 2005;280:2205\u201312.","journal-title":"J Biol Chem"},{"key":"2035_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.cdd.4401649","volume":"12","author":"M MacFarlane","year":"2005","unstructured":"MacFarlane M, Inoue S, Kohlhaas SL, Majid A, Harper N, Kennedy DB, et al. Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell Death Differ. 2005;12:773\u201382.","journal-title":"Cell Death Differ."},{"key":"2035_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/40657","volume":"388","author":"M Irmler","year":"1997","unstructured":"Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190\u20135.","journal-title":"Nature."},{"key":"2035_CR28","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/sj.leu.2402287","volume":"15","author":"A Olsson","year":"2001","unstructured":"Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, et al. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D. Leukemia. 2001;15:1868\u201377.","journal-title":"Leukemia."},{"key":"2035_CR29","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.leu.2403946","volume":"19","author":"SH Kaufmann","year":"2005","unstructured":"Kaufmann SH, Steensma DP. On the TRAIL of a new therapy for leukemia. Leukemia. 2005;19:2195\u2013202.","journal-title":"Leukemia."},{"key":"2035_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.canlet.2011.06.016","volume":"332","author":"N Droin","year":"2013","unstructured":"Droin N, Guery L, Benikhlef N, Solary E. Targeting apoptosis proteins in hematological malignancies. Cancer Lett. 2013;332:325\u201334.","journal-title":"Cancer Lett"},{"key":"2035_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/QAD.0b013e32831cb907","volume":"23","author":"JP Herbeuval","year":"2009","unstructured":"Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Vaccari M, Cecchinato V, et al. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. Aids. 2009;23:35\u201340.","journal-title":"Aids."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02035-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02035-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T08:03:43Z","timestamp":1698998623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02035-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-02035-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}